Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Dr. Urano... "Dr. Urano, Hope all is

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
Posted On: 11/22/2014 11:54:38 PM
Posted By: nelito
Dr. Urano...

"Dr. Urano,



Hope all is well. It is obvious that finding a cure for Wolframs and Type 1 Diabetes is not YET within ANYONE'S grasp. Please help me understand your latest blog. To replace the damaged tissues, you are going to use stem cells, correct? What will prevent those stem cells from being damaged AGAIN? Also, to protect the "remaining cells from cell death" you will use trophic factors. I know that MANF will protect the remaining tissues from cell death, however, how will MANF be able to prevent the replaced tissues from being damaged again?



P.S. May God's hand guide you and your team in finding this illusive cure - you can do it! My family HAS, continues to HAVE, and will ALWAYS believe in you. You are the chosen one.



神の手があなたを導く可能性 :-)

The XXX Family"

"To The Pais Family,



I've realized I can use internet in the airplane. Thank you for your kind words. Here are my answers.




1. We may need to genetically modified stem cells from patients. In Type 1 diabetes, we know the immunogenic parts of insulin. By replacing the immunogenic part with less immnogenic part, we may be able to prevent the death of new beta cells derived from stem cells.




2. It seems like MANF has two effects, proliferation of remaining tissues and protection of remaining tissues from cell death by modulating the function of cell survival enzyme. We may be able to activate this specific cell survival enzyme by a drug.




Please feel free to contact me if you have any questions.




Take care,


Fumi"

P.S. No matter what the approach is, it seems as if MANF will be used in some shape or form. I have a feeling AMBS is about to "Rock the House"!

Manolo


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us